On November 7th, the 10th revision of the SCCS’s Notes of Guidance has been released. If you work in cosmetology, you know the importance of this document used to “provide guidance to public authorities and Read more…
This year, the ESTIV (European Society of Toxicology In Vitro) congress took place in Berlin and was again a very interesting symposium. The plenary session was open by a presentation on 3D models made by bioengineering Read more…
Are your interested in meaning full images and high content analysis to asses your compounds properties ? Pierre-Jean, our dermocosmetic expert, will be present at Cosmetic 360 (the international trade fair for innovative ideas and Read more…
The 20th International Congress on In Vitro Toxicology (ESTIV2018) is coming and it will be a great occasion for HCS-Pharma to showcase our current co-development, with the institute du thorax of Nantes and the RHU Read more…
Every year around 10 millions of animals are used to assess compound’s safety, with a total cost estimated to 3 billions euro. Despite animal testing is mandatory by OECD to guarantee consumer safety, toxicologists are Read more…
The first keynote of professor Philip Steven was a passionated overview of neurosciences between non-human and human research
HCS/HCA is a great way to predict drugs toxicity
This year, the ESTIV (European Society of Toxicology In Vitro) congress took place at Juan-les-Pins, from October 17 to October 20, and was about In Vitro Toxicology for Human Safety
We are very happy to present you Pierre-Jean Ferron, who joined HCS Pharma as a study director, specialized in cellular biology and high content analysis.
Genetic Engineering & Biotechnology News (GEN) organise a free webinar about HCS ans HCA use in drug toxicity and genotoxicity testing. High-content analysis (HCA) and high-content screening (HCS) enable imaging of large numbers of cellular Read more…